Background Axial spondyloarthritis (axSpA) impairs trunk strength, mobility and cardiorespiratory fitness. Despite exercise ...
The hallmark of the autoimmune disease ankylosing spondylitis is inflammation of the sacroiliac joint—the joint at the base of the spine that connects it to the pelvic bones. That said, there are a ...
Ivarmacitinib, a highly selective Janus kinase 1 (JAK1) inhibitor, tamed ankylosing spondylitis with sustained efficacy through 24 weeks in a phase 2/3 trial. A phase 2/3 trial in China evaluated the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback